PES Statement Supporting Access to Gender Care The Pediatric Endocrine Society supports a patient and family/caregiver-centered approach to healthcare for…
Read MoreMore Articles
Adriana Rodríguez González, MD I am currently a 3rd year Pediatric Endocrinology Fellow at UPMC Children’s Hospital in Pittsburgh, PA. I received my undergraduate degree at the University of Puerto Rico…
Read MoreBrief Therapeutic Update from PES Drugs and Therapeutics Committee iLet ® Bionic Pancreas On May 19, 2023, the U.S. Food and Drug Administration approved the Beta Bionics iLet ACE…
Read MoreBrief Therapeutic Update from PES Drugs and Therapeutics Committee Sogroya® (somapactian) Once weekly Sogroya® (somapacitan-beco, Novo Nordisk) was approved by the United States Food and Drug Administration (FDA) for treatment…
Read MoreJessika Weber, DO My name is Jessika, and I am a current 2nd year Pediatric Endocrinology Fellow at the University of Utah in Salt Lake City, UT. I received my…
Read MoreBrief Therapeutic Update from PES Drugs and Therapeutics Committee The MiniMed™780G System The MiniMed 780G System from Medtronic was approved by the US Food and Drug Administration on April 21,…
Read MoreHistorical Tidbit: Hakaru Hashimoto, M.D. (May 4, 1881 to January 9, 1934) and Hashimoto’s Disease Submitted by: Alan D. Rogol, MD, Ph.D. Hakaru Hashimoto was a Japanese doctor and medical…
Read MoreNovo Nordisk announced that due to significant demands, they are only able to supply limited quantities of 0.25 mg, 0.5 mg, and 1 mg dose strengths of Wegovy to wholesalers…
Read MoreNaiomi Gunaratne-Breaux, MD I am currently a rising 3rd year fellow in pediatric endocrinology at University of Chicago Medicine Comer Children’s Hospital in Chicago, IL. I received my undergraduate degree…
Read More